Pharmathene, Inc. (f/k/a PIP)

[Northrock]

it means the stock is very undervalued

$3.10 is current price - $2.91 div = .19/share

market is giving this Anthrax & anti-bioteror/counter-terrorism stock a price of...

.19 arbitrary price x outstanding shares = $13M

with $5M in annual revenues and zero debt

look at other biotech stocks and their relative valuations
(some don't even have any product and/or sales yet have 8 & 9 digit sized market caps)

this pig should fly towards $5/share sometime in the next 2 months